CARISMA THERAPEUTICS INC CARM
$0.01
+5.2% 52w: $0.00 – $0.45
Latest 13F among current holders filed 1 month ago (May 13, 2026)
Price — last 12 months
research preview data0.000.230.45
Jun 20, 2025 Jul 2, 2026
Institutional holders
3
-4 QoQ
13F value
$48K
-28.5% QoQ
Smart-money holders
1
signal tier ≥ 2
New smart buyers
0
Q1 2026
Institutional value by quarter
Number of holders
Who owns CARM?
Q1 2026 filings| Fund | Type | Shares | Value | % of fund | Change |
|---|---|---|---|---|---|
| Merck & Co., Inc. ★3 | Fundamental concentrated | 1.5M | $48K | 0.0% | Held |
| Union Bancaire Privee, UBP SA | Other | 785 | $22 | 0.0% | Held |
| Ascentis Independent Advisors | Other | 200 | $6 | 0.0% | New |
Exits are not a bearish signal: our backtest shows stocks specialists exit keep outperforming for 3+ quarters — selling usually means profit-taking, not a forecast.
Explore related
Top funds holding CARM